- 1.
Saudubray JM, van den Berghe G, Walter JH. Inborn Metabolic Diseases. Diagnosis and Treatment. 5. utg. New York, NY: Springer, 2012: 192–5.
- 2.
Taylor MR, Hurley JB, Van Epps HA et al. A zebrafish model for pyruvate dehydrogenase deficiency: rescue of neurological dysfunction and embryonic lethality using a ketogenic diet. Proc Natl Acad Sci U S A 2004; 101: 4584–9. [PubMed][CrossRef]
- 3.
Blass JP, Avigan J, Uhlendorf BW. A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 1970; 49: 423–32. [PubMed][CrossRef]
- 4.
Sperl W, Fleuren L, Freisinger P et al. The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders. J Inherit Metab Dis 2015; 38: 391–403. [PubMed][CrossRef]
- 5.
Patel KP, O'Brien TW, Subramony SH et al. The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab 2012; 105: 34–43. [PubMed][CrossRef]
- 6.
DeBrosse SD, Okajima K, Zhang S et al. Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex (PDC) deficiency: lack of correlation with genotype. Mol Genet Metab 2012; 107: 394–402. [PubMed][CrossRef]
- 7.
Wexler ID, Hemalatha SG, McConnell J et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 1997; 49: 1655–61. [PubMed][CrossRef]
- 8.
De Meirleir L. Disorders of pyruvate metabolism. Handb Clin Neurol 2013; 113: 1667–73. [PubMed][CrossRef]
- 9.
Lissens W, De Meirleir L, Seneca S et al. Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 2000; 15: 209–19. [PubMed][CrossRef]
- 10.
Valle D, Antonarakis S, Ballabio A. The Online Metabolic and Molecular Bases of Inherited Disease. https://ommbid.mhmedical.com/content.aspx?bookid=971§ionid=62633368&jumpsectionID=62633384#1102885218 Lest 19.8.2019.
- 11.
Neal E. Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. New York, NY: Wiley-Blackwell, 2015.
- 12.
Owen OE, Morgan AP, Kemp HG et al. Brain metabolism during fasting. J Clin Invest 1967; 46: 1589–95. [PubMed][CrossRef]
- 13.
Bachmann-Gagescu R, Merritt JL, Hahn SH. A cognitively normal PDH-deficient 18-year-old man carrying the R263G mutation in the PDHA1 gene. J Inherit Metab Dis 2009; 32: 123–6. [PubMed][CrossRef]
- 14.
Sofou K, Dahlin M, Hallböök T et al. Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes. J Inherit Metab Dis 2017; 40: 237–45. [PubMed][CrossRef]
- 15.
van Dongen S, Brown RM, Brown GK et al. Thiamine-Responsive and Non-responsive Patients with PDHC-E1 Deficiency: A Retrospective Assessment. JIMD Rep 2015; 15: 13–27. [PubMed]
- 16.
Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitamin B1. Geneve: European Commission, Health & Consumer Protection Directorate-General, Scientific Committee on Food, 2001. https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_scf_out93_en.pdf Lest 19.8.2019.
- 17.
Stacpoole PW, Kerr DS, Barnes C et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 2006; 117: 1519–31. [PubMed][CrossRef]
- 18.
Kaufmann P, Engelstad K, Wei Y et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 2006; 66: 324–30. [PubMed][CrossRef]
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.